Abstract
This paper covers key quality assurance/quality control issues from a Canadian perspective. Canadian Good Manufacturing Practices (GMP) regulations and guidelines, present and future, are discussed. The Canadian situation with respect to GMPs for active pharmaceutical ingredients (APIs) is explained. GMPs, with a focus on APIs, are discussed. A future direction for GMPs for APIs is offered. Key Canadian GMP regulation and guideline issues in development are reviewed. Concerns for APIs manufactured without GMP compliance are expressed, suggestions for API GMP requirements are offered, guiding principles for GMP regulations are suggested, a need for uniform quality standards is stated, and quality standard compliance advice for drug exporters to Canada is offered. ISO 9000 as not being a substitute for GMP compliance is also mentioned.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
